Audiologists in North Hills, CA Accepting Medicare
5 Audiologists found. Showing 1 - 5
 Procare Health Services, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 15034 Providence Ln, North Hills, CA 91343 Phone: 818-773-9080 Fax: 818-895-8625 |
 Janet K Endo Audiologist Medicare: Not Enrolled in Medicare Practice Location: 16111 Plummer Street, Sepulveda Ambulatory Care Center #126, North Hills, CA 91343 Phone: 818-891-7711 |
Mrs. Jamie Tara Spector, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 16111 Plummer St, Audiology (126), North Hills, CA 91343 Phone: 818-891-7711 Fax: 818-895-5886 |
Baneet Mushiana Audiologist Medicare: Not Enrolled in Medicare Practice Location: 16111 Plummer St, North Hills, CA 91343 Phone: 916-995-9849 |
Ms. Dianne Vernalene Smith, M.S. Audiologist Medicare: Medicare Enrolled Practice Location: 15034 Providence Ln, North Hills, CA 91343 Phone: 818-773-9080 |
News Archive
CD8 alpha+ dendritic cells can help the body beat back infection
The same trait that makes a rare immune cell invaluable in fighting some infections also can be exploited by other diseases to cause harm, two new studies show.
Researchers identify new class of regulatory RNAs involved in cancer pathologies
A team of researchers at the Institute of Oncology Research has identified a new class of regulatory RNAs, which are able to act as molecular switches and can contribute in controlling the genetic evolution processes that are responsible for some cancer pathologies.
RMR can non-invasively, quickly and accurately detect presence of sCAD
Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.
Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination
Eli Lilly and Company announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
› Verified 7 days ago
Physical Therapists
Occupational Therapists
Audiologists
Optometrists
Speech-Language Pathologists
Chiropractors